ERBB2 and triple-negative breast carcinoma: It was previously reported that the TIPIN mRNA level is significantly upregulated in breast cancer, particularly in the most proliferative and poor prognosis-related breast cancer subtypes (triple negative breast cancer, HER2, and Luminal B).